Exact Sciences Partners with Carlos Ponce to Raise Awareness of Colon Cancer in Hispanic Community

Exact Sciences, a leading provider of cancer screening and diagnostic tests, is proud to announce a new partnership with award-winning Hispanic actor, TV p...

November 19, 2024 | Tuesday | News
EMA Committee Recommends Approval of Opdivo® + Yervoy® for First-Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

 Bristol Myers Squibb (NYSE: BMY) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...

November 18, 2024 | Monday | News
EMA CHMP Issues Positive Opinion for Lecanemab in Early Alzheimer’s Disease

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusett...

November 15, 2024 | Friday | News
EMA Committee Recommends Approval of Sarclisa in Combination with VRd for Transplant-Ineligible Multiple Myeloma

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval ...

November 15, 2024 | Friday | News
Exact Sciences to Present Key Findings on Multi-Cancer Early Detection Test at AACR Conference in San Diego

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three abstracts highlighting significant adv...

November 14, 2024 | Thursday | News
Tirzepatide Reduces Type 2 Diabetes Risk by 94% in Three-Year SURMOUNT-1 Study, Lilly Reports

SURMOUNT-1 results show a 94% reduction in risk of progression to type 2 diabetes across all pooled doses of tirzepatide compared to placebo over three y...

November 14, 2024 | Thursday | News
Alexion and Merck Report Positive Phase 3 KOMET Trial Results for KOSELUGO in Treating Adult Patients with Neurofibromatosis Type 1

Alexion, AstraZeneca Rare Disease and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced positive topline results from the ...

November 13, 2024 | Wednesday | News
Red Ginseng Shown to Boost Bone and Intestinal Health, Michigan State Study Reveals

Professor Narayanan Parameswaran's team at the Department of Physiology at Michigan State University announced the results of a study that s...

November 12, 2024 | Tuesday | News
GenScript Biotech Expands with New Operations and Logistics Center in Sydney, Enhancing Support for Australian Biotech

GenScript Biotech Corporation ("GenScript"), a global leader in life sciences services and products, has announced the establishment of new operations site...

November 11, 2024 | Monday | News
Dragonfly Therapeutics to Present Groundbreaking Preclinical Data on DF6215 and DF9001 at SITC 2024

 a clinical-stage biotechnology company developing novel immunotherapies, announced the company will deliver poster presentations at the Society for I...

November 08, 2024 | Friday | News
QIAGEN’s QIAstat-Dx Meningitis/Encephalitis Panel Cleared by FDA for Clinical Use

QIAstat-Dx Meningitis/Encephalitis Panel cleared in the U.S. for use in clinical settings to help diagnose central nervous system infections // Fourth ...

November 04, 2024 | Monday | News
Novo Nordisk's SELECT Trial Reveals Semaglutide 2.4 mg Reduces Hospital Admissions for Patients with Obesity and Cardiovascular Disease

Novo Nordisk presented an exploratory post hoc analysis from the SELECT phase 3 cardiovascular outcomes trial that showed semaglutide 2.4 mg significantly ...

November 04, 2024 | Monday | News
American Lung Association Launches Free Lung Cancer Screenings for Illinois Residents in Honor of Lung Cancer Awareness Month

November is Lung Cancer Awareness Month, and the American Lung Association (Lung Association) is kicking it off by offering free lung cancer screenings to&...

November 01, 2024 | Friday | News
Pangea Laboratory Partners with Unilabs to Launch Bladder CARE™ Assay in Switzerland

Pangea Laboratory has partnered with Unilabs, a leading European provider of clinical laboratory testing and diagnostic imaging services, to bring the Blad...

November 01, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close